Profil
Dr. Garry Pairaudeau is a Chief Technology Officer at Exscientia AI Ltd. and a Chief Executive Officer at DaltonTx Ltd. Dr. Pairaudeau was previously employed as a Chief Technology Officer by Exscientia Ltd. and a Head-External Sciences by AstraZeneca PLC.
He received his undergraduate degree from The University of Southampton and a doctorate degree from The University of Southampton.
Postes actifs de Garry Pairaudeau
| Sociétés | Poste | Début |
|---|---|---|
Exscientia AI Ltd.
Exscientia AI Ltd. Pharmaceuticals: GenericHealth Technology Provides AI and machine learning techniques based drug discovery services | Directeur Technique/Scientifique/R&D | 01/11/2020 |
Anciens postes connus de Garry Pairaudeau
| Sociétés | Poste | Fin |
|---|---|---|
| EXSCIENTIA PLC | Directeur Technique/Scientifique/R&D | 30/06/2023 |
| ASTRAZENECA PLC | Corporate Officer/Principal | 01/11/2020 |
Formation de Garry Pairaudeau
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
AstraZeneca PLC
AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
The University of Southampton
The University of Southampton Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Exscientia AI Ltd.
Exscientia AI Ltd. Pharmaceuticals: GenericHealth Technology Provides AI and machine learning techniques based drug discovery services | Health Technology |
Exscientia Plc
Exscientia Plc Packaged SoftwareTechnology Services Function as an investment holding company whose subsidiaries provides artificial intelligence and machine learning services | Technology Services |
















